Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
liečivo je panitumumab 20 mg/ ml.
the active substance is panitumumab 20 mg/ ml.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
liek obsahuje účinnú látku panitumumab.
it contains the active substance panitumumab.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
panitumumab môže ovplyvňovať schopnosť žien otehotnieť.
panitumumab may impact the ability of a woman to become pregnant.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
vectibix 20 mg/ml infúzny koncentrát panitumumab
vectibix 20 mg/ml concentrate for solution for infusion panitumumab
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
vectibix 20 mg/ ml sterilný koncentrát panitumumab i. v.
vectibix 20 mg/ ml sterile concentrate panitumumab iv
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
Účinná látka lieku vectibix, panitumumab, je monoklonálna protilátka.
the active substance in vectibix, panitumumab, is a monoclonal antibody.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
nie je známe, či sa panitumumab vylučuje do materského mlieka u ľudí.
it is unknown whether panitumumab is excreted in human breast milk.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vectibix je liek proti rakovine, ktorý obsahuje účinnú látku panitumumab.
vectibix is a cancer medicine that contains the active substance panitumumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dôvodom môžu byť pacienti užívajúci panitumumab po progresii v skupine randomizovaných na bsc.
this may be due to patients receiving panitumumab after progression among those randomized to bsc.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
pretože ľudský igg sa vylučuje do materského mlieka, aj panitumumab by mohol byť vylučovaný.
because human igg is secreted into human milk, panitumumab might also be secreted.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vectibix obsahuje liečivo panitumumab, ktorý patrí do skupiny liekov nazývaných monoklonálne protilátky.
vectibix contains the active substance panitumumab, which belongs to a group of medicines called monoclonal antibodies.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
kožné reakcie boli najčastejšie zaznamenané nežiaduce reakcie u pacientov dostávajúcich panitumumab v kombinácii s chemoterapiou.
skin reactions were the most frequently occurring adverse reactions in patients receiving panitumumab in combination with chemotherapy.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
panitumumab sa viaže na doménu egfr viažucu ligand a inhibuje receptorovú autofosforyláciu indukovanú všetkými známymi ligandami egfr.
panitumumab binds to the ligand binding domain of egfr and inhibits receptor autophosphorylation induced by all known egfr ligands.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
liečba panitumumabom bola prerušená z dôvodu štatisticky významného zníženia pfs u pacientov používajúcich panitumumab pozorovaného v predbežnej analýze.
panitumumab treatment was discontinued due to a statistically significant reduction in pfs in patients receiving panitumumab observed in an interim analysis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hodnotenia štúdií na zvieratách in vitro a in vivo preukázali, že panitumumab inhibuje rast a prežívanie nádorových buniek s expresiou egfr.
in vitro assays and in vivo animal studies have shown that panitumumab inhibits the growth and survival of tumour cells expressing egfr.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ak ste alergický na panitumumab alebo na ktorúkoľvek z ďalších zložiek tohto lieku (uvedených v časti 6).
if you are allergic to panitumumab or any of the other ingredients of this medicine (listed in section 6).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
informácia, že u pacientov s nádormi s mutovaným génom ras preukázal panitumumab nepriaznivý účinok v kombinácii s folfox a žiadny účinok v monoterapii a v kombinácii s folfiri
information that in patients with mutant ras tumours panitumumab has shown a detrimental effect in combination with folfox and no effect as monotherapy and in combination with folfiri
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
panitumumab bol vyvinutý tak, aby sa naviazal na receptor epidermálneho rastového faktora, ktorý sa nachádza na povrchu niektorých buniek vrátane buniek určitých tumorov.
panitumumab has been designed to attach to egfr, which can be found on the surface of certain cells, including cells in some tumours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
okrem indikovaných prípadov, sú popísané nežiaduce reakcie hlásené z klinických štúdií u pacientov s metastatickým kolorektálnym karcinómom, ktorí dostávali samotný panitumumab:
except where indicated, the data describe adverse reactions reported from clinical studies in patients with metastatic colorectal carcinoma who received panitumumab as a single agent:
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
dokázalo sa, že panitumumab spôsobuje fetálny potrat a/ alebo úmrtie plodu u opíc cynomolgus pri podávaní počas organogenézy v dávkach približne rovnakých ako je odporúčaná dávka u ľudí.
panitumumab has been shown to cause foetal abortions and/ or foetal deaths in cynomolgus monkeys when administered during the period of organogenesis at doses approximately equivalent to the recommended human dose.
Last Update: 2012-04-12
Usage Frequency: 2
Quality: